Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunther Becher

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Medical Research and Opinion|June 11, 2014
Re: Baker DL et al. Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. Curr Med Res Opin 2014;30:913-22Pavel Strohner, Gunther Becher
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 17, 2008
Evaluation of H2O2 and pH in exhaled breath condensate samples: methodical and physiological aspectsHenri Knobloch, Gunther Becher, Manfred Decker, et al.
Journal of Immunoassay & Immunochemistry|January 18, 2013
The recovery-ELISA--a novel assay technique to monitor therapy with humanized antibodies: the example of omalizumabPavel Strohner, Stephanie Korn, Roland Buhl, et al.
Journal of Medical Microbiology|December 21, 2016
Detection of mycobacteria by volatile organic compound analysis of invitro cultures using differential ion mobility spectrometryRoman Purkhart, Gunther Becher, Petra Reinhold, et al.
Clinical Chemistry and Laboratory Medicine|August 2, 2012
The recoveryELISA--a newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapyPavel Strohner, Antonia Staatz, Dieter Sarrach, et al.
Journal of Cardiology|April 15, 2024
Cluster analysis of volatile organic compounds - A pilot study in patients with severe acute decompensated heart failureLukas Butter, Anja Haase-Fielitz, Michael Zänker, et al.
Mediators of Inflammation|March 30, 2007
Detection of erythropoietin in exhaled breath condensate of nonhypoxic subjects using a multiplex bead arrayChristian Schumann, Kathy Triantafilou, Stefan Krueger, et al.
Journal of Breath Research|April 23, 2011
Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometryRoman Purkhart, Heike Köhler, Elisabeth Liebler-Tenorio, et al.
Clinical and Experimental Rheumatology|August 30, 2017
Improved adalimumab dose decision with comprehensive diagnostics dataMichael Zänker, Gunther Becher, Olga Arbach, et al.
Respiratory Medicine|August 14, 2012
Monitoring free serum IgE in severe asthma patients treated with omalizumabStephanie Korn, Ina Haasler, Florian Fliedner, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Medical Research and Opinion|June 11, 2014
Re: Baker DL et al. Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. Curr Med Res Opin 2014;30:913-22Pavel Strohner, Gunther Becher
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 17, 2008
Evaluation of H2O2 and pH in exhaled breath condensate samples: methodical and physiological aspectsHenri Knobloch, Gunther Becher, Manfred Decker, et al.
Journal of Immunoassay & Immunochemistry|January 18, 2013
The recovery-ELISA--a novel assay technique to monitor therapy with humanized antibodies: the example of omalizumabPavel Strohner, Stephanie Korn, Roland Buhl, et al.
Journal of Medical Microbiology|December 21, 2016
Detection of mycobacteria by volatile organic compound analysis of invitro cultures using differential ion mobility spectrometryRoman Purkhart, Gunther Becher, Petra Reinhold, et al.
Clinical Chemistry and Laboratory Medicine|August 2, 2012
The recoveryELISA--a newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapyPavel Strohner, Antonia Staatz, Dieter Sarrach, et al.
Journal of Cardiology|April 15, 2024
Cluster analysis of volatile organic compounds - A pilot study in patients with severe acute decompensated heart failureLukas Butter, Anja Haase-Fielitz, Michael Zänker, et al.
Mediators of Inflammation|March 30, 2007
Detection of erythropoietin in exhaled breath condensate of nonhypoxic subjects using a multiplex bead arrayChristian Schumann, Kathy Triantafilou, Stefan Krueger, et al.
Journal of Breath Research|April 23, 2011
Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometryRoman Purkhart, Heike Köhler, Elisabeth Liebler-Tenorio, et al.
Clinical and Experimental Rheumatology|August 30, 2017
Improved adalimumab dose decision with comprehensive diagnostics dataMichael Zänker, Gunther Becher, Olga Arbach, et al.
Respiratory Medicine|August 14, 2012
Monitoring free serum IgE in severe asthma patients treated with omalizumabStephanie Korn, Ina Haasler, Florian Fliedner, et al.
Pageof 1